CS191276B2 - Process for preparing optically active or racemic omega-nor-cycloalkyl-13,14-dehydroprostaglandines - Google Patents

Process for preparing optically active or racemic omega-nor-cycloalkyl-13,14-dehydroprostaglandines

Info

Publication number
CS191276B2
CS191276B2 CS755964A CS596475A CS191276B2 CS 191276 B2 CS191276 B2 CS 191276B2 CS 755964 A CS755964 A CS 755964A CS 596475 A CS596475 A CS 596475A CS 191276 B2 CS191276 B2 CS 191276B2
Authority
CS
Czechoslovakia
Prior art keywords
dehydroprostaglandines
omega
racemic
cycloalkyl
optically active
Prior art date
Application number
CS755964A
Other languages
Czech (cs)
English (en)
Inventor
Carmelo Gandolfi
Renato Pellegate
Roberto Ceserani
Maria M Usardi
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of CS191276B2 publication Critical patent/CS191276B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018—Esters of cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/564—Three-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
CS755964A 1974-09-25 1975-09-02 Process for preparing optically active or racemic omega-nor-cycloalkyl-13,14-dehydroprostaglandines CS191276B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT27654/74A IT1053781B (it) 1974-09-25 1974-09-25 Omega nor cicloalcil 13.14 deidro prostaglandine

Publications (1)

Publication Number Publication Date
CS191276B2 true CS191276B2 (en) 1979-06-29

Family

ID=11222055

Family Applications (1)

Application Number Title Priority Date Filing Date
CS755964A CS191276B2 (en) 1974-09-25 1975-09-02 Process for preparing optically active or racemic omega-nor-cycloalkyl-13,14-dehydroprostaglandines

Country Status (24)

Country Link
US (2) US4035415A (xx)
JP (2) JPS5839156B2 (xx)
AT (1) AT351184B (xx)
BE (1) BE832983A (xx)
CA (1) CA1083569A (xx)
CH (1) CH617186A5 (xx)
CS (1) CS191276B2 (xx)
CY (1) CY954A (xx)
DE (1) DE2539116C2 (xx)
DK (1) DK155316C (xx)
FI (1) FI63932C (xx)
FR (2) FR2285866A1 (xx)
GB (1) GB1483880A (xx)
HK (1) HK42478A (xx)
HU (1) HU174287B (xx)
IL (1) IL48043A (xx)
IT (1) IT1053781B (xx)
KE (1) KE2851A (xx)
MY (1) MY7800321A (xx)
NL (1) NL187354C (xx)
NO (1) NO146357C (xx)
SE (1) SE422057B (xx)
SU (1) SU652889A3 (xx)
ZA (1) ZA755420B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU501803B2 (en) * 1975-03-21 1979-06-28 Farmitalia Carlo Erba S.P.A. Fluoro-prostaglandins
DE2655004C3 (de) * 1976-12-02 1980-06-19 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von bicyclischen Laktonen
IT1088966B (it) * 1977-11-15 1985-06-10 Erba Carlo Spa 13,14-dideidro-prostaglandine
US4543353A (en) * 1981-11-27 1985-09-24 Farmitalia Carlo Erba S.P.A. Ester and amide derivatives of 13,14-didehydro prostaglandins
ES2213504T1 (es) * 1988-09-06 2004-09-01 Pfizer Health Ab Derivados de prostaglandina para el tratamiento del glaucoma o hipertension ocular.
DE4024347A1 (de) * 1990-07-27 1992-01-30 Schering Ag Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
US5741810A (en) * 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
CZ305221B6 (cs) * 2013-12-10 2015-06-17 Univerzita Pardubice Způsob přípravy (3aR,4S,5R,6aS)-4-[(3S)-5-cyklohexyl-3-hydroxypent-1-yn-1-yl]-5-(ethoxymethoxy)-hexahydro-2H-cyklopenta[b]furan-2-onu

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843713A (en) * 1972-04-05 1974-10-22 Ciba Geigy Corp 16-lower alkoxy lower alkyl,-16-20 w-pentano,pge
GB1425962A (en) * 1972-04-13 1976-02-25 Erba Carlo Spa Lactols and lactones
US3876690A (en) * 1973-05-11 1975-04-08 American Cyanamid Co 1-alkoxy-9-keto-prostenoic acid derivatives
US3884909A (en) * 1973-09-24 1975-05-20 Standard Brands Inc Gelatinizable crosslinked cationic starch and method for its manufacture
IT1044796B (it) * 1974-09-06 1980-04-21 Erba Carlo Spa Pgf beta gandolfi
FI71138C (fi) * 1976-12-31 1986-11-24 Erba Farmitalia Foerfarande foer framstaellning av terapeutiskt aktiva bisykliska prostaglandiner

Also Published As

Publication number Publication date
DE2539116C2 (de) 1984-08-02
SU652889A3 (ru) 1979-03-15
ATA656075A (de) 1978-12-15
JPS51125044A (en) 1976-11-01
FI63932B (fi) 1983-05-31
DK390975A (da) 1976-03-26
DK155316B (da) 1989-03-28
GB1483880A (en) 1977-08-24
KE2851A (en) 1978-07-21
CH617186A5 (xx) 1980-05-14
JPS5918391B2 (ja) 1984-04-26
DK155316C (da) 1989-08-14
NL7510452A (nl) 1976-03-29
AU8381075A (en) 1977-02-10
DE2539116A1 (de) 1976-04-08
IL48043A (en) 1979-12-30
SE422057B (sv) 1982-02-15
FR2378757A1 (fr) 1978-08-25
NO146357C (no) 1982-09-15
SE7509764L (sv) 1976-03-26
JPS58135858A (ja) 1983-08-12
NO146357B (no) 1982-06-07
NO753028L (xx) 1976-03-26
IT1053781B (it) 1981-10-10
CA1083569A (en) 1980-08-12
FR2378757B1 (xx) 1980-07-04
AT351184B (de) 1979-07-10
HU174287B (hu) 1979-12-28
HK42478A (en) 1978-08-11
FI752491A (xx) 1976-03-26
JPS5839156B2 (ja) 1983-08-27
ZA755420B (en) 1977-04-27
FI63932C (fi) 1983-09-12
NL187354C (nl) 1991-09-02
MY7800321A (en) 1978-12-31
IL48043A0 (en) 1975-11-25
CY954A (en) 1978-12-22
FR2285866A1 (fr) 1976-04-23
US4361577A (en) 1982-11-30
BE832983A (fr) 1976-03-02
US4035415A (en) 1977-07-12
FR2285866B1 (xx) 1978-12-22

Similar Documents

Publication Publication Date Title
YU82775A (en) Process for preparing new n-phenyl-n-acyl-alanine or glycinesters
HU173057B (hu) Sposob poluchenija 1,3,4-trjokhzamehhjonnykh-4-fenil-piperidinov
HU177952B (en) Process for preparing new 5,9beta-disubstituted 2-tetrahydro-furfuryl-6,7-benzomorphanes
YU81675A (en) Process for preparing 1,1-diaryl-1-oxadiazole-alkylamines
CH609323A5 (en) Process for preparing optically active N-(2-benzhydrylethyl)-N-1-phenylethylamine
HU171870B (hu) Sposob poluchenija novykh 1,4-digidropiridinov
CS191321B2 (en) Process for preparing optically active 11-deoxy-16-aryloxy-omega-tetranorprostaglandines
HU170888B (hu) Sposob poluchenija novykh, opticheski aktivnykh proizvodnykh eburnameninov
CS191276B2 (en) Process for preparing optically active or racemic omega-nor-cycloalkyl-13,14-dehydroprostaglandines
HU173985B (hu) Sposob poluchenija proizvodnykh d-8al'fa,8beta-dvezamehhjonnogo-6-metil-ehrgolina i -ehrgolena
NL7508428A (nl) Werkwijze om polyolen te bereiden.
YU40262B (en) Process for preparing racemic or optically active 4-substituted
CA1017741A (en) Process for preparing 3-fluorocephalosporins
JPS5328146A (en) Process for preparing optically active aresrolone
CS189001B2 (en) Process for preparing optically active 13,14-dehydro-11-deoxyprostaglandines
YU39750B (en) Process for obtaining 2-deutero-3-fluoro-d,l-alanine
NL7509206A (nl) Werkwijze om polyolen te bereiden.
CS191296B2 (en) Process for preparing optically active or racemic fluorprostaglandine
CS188965B2 (en) Process for preparing 9-hydroxy-19,20-bis-nor-prostanic acid
CS191994B2 (en) Process for preparing 3,7-dimethyl-2,6-octadiennitrile
YU119675A (en) Process for preparing optical whiteners
HU173528B (hu) Sposob poluchenija steroid-skobka-16-al'fa,17-b-skobka zakryta-naftalinov
HU171174B (hu) Sposob poluchenija 3,7-dimetil-3-gidroksi-6-okten-nitrila
JPS532460A (en) Process for preparing optically active sulfoxide
YU36916B (en) Process for obtaining new 1-aryloxy-2-hydroxy-4-sec.amino-butanes